Palatin Technologies Inc. buy stratec
Start price
08.11.17
/
50%
€17.38
Target price
28.10.19
€35.00
Performance (%)
10.07%
End price
28.10.19
€19.13
Summary
This prediction ended on 28.10.19 with a price of €19.13. The BUY prediction by stratec finished with a performance of 10.07%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Palatin Technologies Inc. | - | - | - | - |
| iShares Core DAX® | -0.197% | -1.724% | 12.342% | 55.750% |
| iShares Nasdaq 100 | -3.612% | -3.768% | 0.437% | 80.820% |
| iShares Nikkei 225® | 1.176% | 2.165% | 19.971% | 49.596% |
| iShares S&P 500 | -0.825% | -1.916% | 0.099% | 55.940% |
Comments by stratec for this prediction
In the thread Palatin Technologies diskutieren
stratec stimmt der Buy-Einschätzung von tamam zu
stratec stimmt am 08.11.2017 der Buy-Einschätzung von tamam mit dem Kursziel 0,8€ zu.
Überschrift: tamam stimmt der Buy-Einschätzung von datca zu
- The FDA has extended its action date for its review of Palatin Technologies' (NYSEMKT:PTN) Vyleesi (bremelanotide) for hypoactive sexual desire disorder in postmenopausal women to June 23.
- FDA approval will trigger a $60M milestone payment from licensor AMAG Pharmaceuticals (NASDAQ:AMAG).
Stopped prediction by stratec for Palatin Technologies Inc.
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€17.63
11.11.19
11.11.19
€50.00
04.11.21
04.11.21
-49.08%
05.11.21
05.11.21
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€19.13
28.10.19
28.10.19
-
11.11.19
11.11.19
-7.84%
11.11.19
11.11.19